Description
The FcγRI ADCP Bioassay is a bioluminescent cell-based assay for measuring the potency and stability of antibodies and other biologics with Fc domains that bind and activate FcγRI. The assay consists of a genetically engineered Jurkat T cell line that expresses the high-affinity human FcγRI and a luciferase reporter. The bioassay workflow is simple, robust, consistent and overcomes many of the limitations of traditional methods